z-logo
open-access-imgOpen Access
Molecular and Phenotypic Characteristics of Methicillin-Resistant and Vancomycin-Intermediate Staphylococcus aureus Isolates from Patients with Septic Arthritis
Author(s) -
WeiYao Wang,
Shih-Yi Lee,
TzongShi Chiueh,
JangJih Lu
Publication year - 2009
Publication title -
journal of clinical microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.349
H-Index - 255
eISSN - 1070-633X
pISSN - 0095-1137
DOI - 10.1128/jcm.00539-09
Subject(s) - multilocus sequence typing , microbiology and biotechnology , staphylococcus aureus , septic arthritis , vancomycin , sccmec , methicillin resistant staphylococcus aureus , antibiotics , biology , staphylococcal infections , quinolone , virology , medicine , genotype , arthritis , immunology , bacteria , genetics , gene
Staphylococcus aureus is one of the most common pathogens in community- and hospital-associated infections and frequently causes severe and intractable infections in osteoarticular tissues.S. aureus isolates that are resistant to methicillin (meticillin) (MRSA isolates) and intermediately resistant to vancomycin (VISA isolates) have emerged. In this report, we described two patients, one female and one male, diagnosed with septic arthritis due toS. aureus infections. A total of 13 MRSA isolates were obtained from these two patients. All but one isolate belonged to the VISA group. All seven isolates from the female patient were determined to be community associated, multilocus sequence type (MLST) 59, and staphylococcal cassette chromosomemecA (SCCmec ) type IV; had direct repeat units (DRUs) of nine repeats; werespa type t437; and were susceptible to sulfa and quinolone antibiotics. The other six isolates, from the male patient, were determined to be hospital associated, MLST 239, and SCCmec type III; had DRUs of 14 repeats; werespa type t037; and were resistant to sulfa and quinolone antibiotics. All 13 MRSA isolates were inagr group I, werepvl negative, and showed no evidence of any association between vancomycin resistance and autolysis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom